BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6238733)

  • 1. Pulmonary and systemic immunoregulatory changes during the development of experimental asbestosis.
    Rola-Pleszczynski M; Gouin S; Bégin R
    Clin Exp Immunol; 1984 Nov; 58(2):325-34. PubMed ID: 6238733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asbestos related changes in pulmonary and systemic immune responses--early enhancement followed by inhibition.
    Rola-Pleszczynski M; Lemaire I; Sirois P; Massé S; Bégin R
    Clin Exp Immunol; 1982 Aug; 49(2):426-32. PubMed ID: 7127910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early effects of low-doses exposure to asbestos on local cellular immune responses in the lung.
    Rola-Pleszczynski M; Massé S; Sirois P; Lemaire I; Bégin R
    J Immunol; 1981 Dec; 127(6):2535-8. PubMed ID: 7299135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses.
    Mizushima Y; Wepsic HT; Yamamura Y; Desilva MA
    Clin Exp Immunol; 1984 Aug; 57(2):371-9. PubMed ID: 6235988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the immunoregulatory functions of alveolar macrophages in cell-mediated immune responses.
    Igietseme JU; Herscowitz HB
    Reg Immunol; 1990; 3(1):46-55. PubMed ID: 2171621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role for alveolar macrophages in humoral and cell-mediated immune responses: evidence for suppressor and enhancing functions.
    Pennline KJ; Herscowitz HB
    J Reticuloendothel Soc; 1981 Sep; 30(3):205-17. PubMed ID: 6457150
    [No Abstract]   [Full Text] [Related]  

  • 7. Bovine con A-induced suppressor cells: generation, macrophage requirements and possible mechanisms of regulatory action.
    Smith WG; Usinger WR; Splitter GA
    Immunology; 1981 May; 43(1):91-100. PubMed ID: 6454650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alveolar macrophages. II. Inhibition of lymphocyte proliferation by purified macrophages from rat lung.
    Holt PG
    Immunology; 1979 Jun; 37(2):429-36. PubMed ID: 468308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma.
    Haslam PL; Lukoszek A; Merchant JA; Turner-Warwick M
    Clin Exp Immunol; 1978 Feb; 31(2):178-88. PubMed ID: 648028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage activity in asbestos related diseases.
    Tarkowski M; Górski P
    Pol J Occup Med Environ Health; 1991; 4(2):115-25. PubMed ID: 1799637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of CFUC suppressor T cells in vitro. II. Effect of PHA, PWM, and Con-A on bone marrow and peripheral blood lymphocytes from healthy donors.
    Podesta M; Frassoni F; van Lint MT; Piaggio G; Marmont A; Bacigalupo A
    Exp Hematol; 1982 Mar; 10(3):256-62. PubMed ID: 6461560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asbestos exposure enhances the release of fibroblast growth factor by sheep alveolar macrophages.
    Lemaire I; Rola-Pleszczynski M; Bégin R
    J Reticuloendothel Soc; 1983 Apr; 33(4):275-85. PubMed ID: 6220151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulation of lung fibroblast growth: alteration in asbestos-induced pulmonary fibrosis.
    Lemaire I; Dubois C; Grondin C; Gingras D
    Clin Exp Immunol; 1986 Oct; 66(1):201-8. PubMed ID: 3026699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immunity in asbestosis.
    Lange A; Smolik R; Chmielarczyk W; Garncarek D; Gielgier Z
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):899-903. PubMed ID: 373690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human lung macrophages enhance and inhibit lymphocyte proliferation.
    Liu MC; Proud D; Schleimer RP; Plaut M
    J Immunol; 1984 Jun; 132(6):2895-903. PubMed ID: 6609963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced interleukin activity following asbestos inhalation.
    Hartmann DP; Georgian MM; Oghiso Y; Kagan E
    Clin Exp Immunol; 1984 Mar; 55(3):643-50. PubMed ID: 6608427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination of 2 types of suppressor T cells by cell surface phenotype and by function: the ability to regulate the contrasuppressor circuit.
    Green DR; Chue B; Gershon RK
    J Mol Cell Immunol; 1983; 1(1):19-30. PubMed ID: 6242848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for TGF-beta in the suppression by murine bronchoalveolar cells of lung dendritic cell initiated immune responses.
    Lipscomb MF; Pollard AM; Yates JL
    Reg Immunol; 1993; 5(3-4):151-7. PubMed ID: 8240933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation.
    Paine R; Mody CH; Chavis A; Spahr MA; Turka LA; Toews GB
    Am J Respir Cell Mol Biol; 1991 Sep; 5(3):221-9. PubMed ID: 1910808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.